A randomized trial of direct mailing of fecal occult blood tests to increase colorectal cancer screening

被引:117
作者
Church, TR
Yeazel, MW
Jones, RM
Kochevar, LK
Watt, GD
Mongin, SJ
Cordes, JE
Engelhard, D
机构
[1] Univ Minnesota, Sch Publ Hlth, Div Environm & Occupat Hlth, Minneapolis, MN 55455 USA
[2] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA
[3] Univ Minnesota, VA Med Ctr, Sch Med, Dept Family Practice & Community Hlth, Minneapolis, MN 55455 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2004年 / 96卷 / 10期
关键词
D O I
10.1093/jnci/djh134
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Although colorectal cancer screening by using a fecal occult blood test (FOBT), flexible sigmoidoscopy, colonoscopy, or barium enema x-ray reduces the incidence of and death from colorectal cancer, the rate of colorectal cancer screening in the general population is low. We conducted a randomized trial consisting of direct mailing of FOBT kits to increase colorectal cancer screening among residents of Wright County, Minnesota, a community in which colorectal cancer screening was promoted. Methods: At baseline, we mailed a questionnaire about colorectal cancer screening to a random sample of Wright County residents aged 50 years or older who were randomly selected from the Minnesota State Driver's License and Identification Card database (estimated N = 1451). The sample was randomly allocated into three equal subgroups: one group (control) received only the questionnaire, one group received FOBT kits by direct mail with reminders, and one group received FOBT kits by direct mail without reminders. Study participants were sent a follow-up questionnaire 1 year after baseline. We used the responses to the questionnaires to estimate the 1-year change in self-reported screening rates in each group and the differences in the changes among the groups, along with the associated bootstrap 95% confidence intervals (CIs). Results: At baseline, the estimated response rate was 86.5%, self-reported adherence to FOBT guidelines was 21.5%, and overall adherence to any colorectal cancer screening test guidelines was 55.8%. The 1-year rate changes in absolute percentage for self-reported adherence to FOBT use were 1.5% (95% CI = -2.9% to 5.9%) for the control group, 16.9% (95% CI = 11.5% to 22.3%) for the directmail-FOBT-with-no-reminders group, and 23.2% (95% CI = 17.2% to 29.3%) for the direct-mail-FOBT-with-reminders group. The I-year rate changes for self-reported adherence to any colorectal cancer screening test were 7.8% (95% CI 3.2% to 12.0%) for the control group, 13.2% (95% CI 8.4% to 18.2%) for the direct-mail-FOBT-with-no-reminders group, and 14.1% (95% CI = 9.1% to 19.1%) for the direct-mail-FOBT-with-reminders group. Conclusion: Direct mailing of FOBT kits combined with follow-up reminders promotes more rapid increases in the use of FOBT and nearly doubles the increase in overall rate of adherence to colorectal cancer screening guidelines in a general population compared with a community-wide screening promotion and awareness campaign.
引用
收藏
页码:770 / 780
页数:11
相关论文
共 49 条
[1]  
Baier M, 2000, CANCER EPIDEM BIOMAR, V9, P229
[2]  
Bejes C, 1992, Fam Pract Res J, V12, P83
[3]  
Bond John H., 1999, American Journal of Medicine, V106, p7S, DOI 10.1016/S0002-9343(98)00339-8
[4]   Progress in cancer screening over a decade: Results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys [J].
Breen, N ;
Wagener, DK ;
Brown, ML ;
Davis, WW ;
Ballard-Barbash, R .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2001, 93 (22) :1704-1713
[5]   American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997 [J].
Byers, T ;
Levin, B ;
Rothenberger, D ;
Dodd, GD ;
Smith, RA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1997, 47 (03) :154-&
[6]  
Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P162
[7]  
Efron B., 1993, INTRO BOOTSTRAP, V57
[8]   COMPARATIVE EDUCATIONAL APPROACHES TO SCREENING FOR COLORECTAL CANCER [J].
ELWOOD, TW ;
ERICKSON, A ;
LIEBERMAN, S .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1978, 68 (02) :135-138
[9]  
Erban S, 2001, Eff Clin Pract, V4, P10
[10]  
Faivre J, 1991, Eur J Cancer Prev, V1, P49